(Reuters) – Drugmaker Biogen will buy all outstanding shares of Sage Therapeutics that it does not already own for $7.22…
Walgreens Boots signals turnaround on track as it tops estimates, shares surge
By Manas Mishra and Sneha S K (Reuters) -Walgreens Boots Alliance beat analysts’ lowered expectations for first-quarter adjusted profit on…
Pfizer must face lawsuit over diversity fellowship program, US court rules
By Nate Raymond (Reuters) -A U.S. appeals court on Friday revived a lawsuit by a conservative group opposed to diversity…
American Airlines’ focus on ESG in 401(k) plan is illegal, US judge rules
By Daniel Wiessner (Reuters) -A federal judge in Texas on Friday said American Airlines violated federal law by basing investment…
Polestar raises hope as order intake rises
(Reuters) – Polestar on Thursday reported rises in fourth-quarter retail sales and order intake, raising optimism amongst jittery investors over…
Trump’s tariff threat spurs auto suppliers to rethink production plans
By Abhirup Roy LAS VEGAS (Reuters) -Global auto suppliers are working out how much of their production can be moved…
Lockheed Martin delivers 110 F-35 fighter jets in 2024
(Reuters) – Lockheed Martin delivered a total of 110 F-35 fighter jets to the United States and its allies in…
AT&T will offer bill credits for outages to ‘make it right’ with customers
By Harshita Mary Varghese (Reuters) – U.S. telecom giant AT&T said on Wednesday it would offer bill credits for network…
JPMorgan files two lawsuits against Greece’s Viva Wallet as legal saga continues
ATHENS (Reuters) – Wall Street bank JP Morgan has filed two lawsuits over its investment in fintech Viva Wallet, the…
Point72 kicks off new private credit strategy, statement shows
NEW YORK (Reuters) – Point72 Asset Management has hired Todd Hirsch, a former senior managing director at Blackstone, to head…